Magi, M.S.; de Lafuente, Y.; Quarta, E.; Palena, M.C.; Ardiles, P.d.R.; Páez, P.L.; Sonvico, F.; Buttini, F.; Jimenez-Kairuz, A.F.
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis. Pharmaceutics 2024, 16, 436.
https://doi.org/10.3390/pharmaceutics16040436
AMA Style
Magi MS, de Lafuente Y, Quarta E, Palena MC, Ardiles PdR, Páez PL, Sonvico F, Buttini F, Jimenez-Kairuz AF.
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis. Pharmaceutics. 2024; 16(4):436.
https://doi.org/10.3390/pharmaceutics16040436
Chicago/Turabian Style
Magi, MarÃa S., Yanina de Lafuente, Eride Quarta, MarÃa C. Palena, Perla del R. Ardiles, Paulina L. Páez, Fabio Sonvico, Francesca Buttini, and Alvaro F. Jimenez-Kairuz.
2024. "Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis" Pharmaceutics 16, no. 4: 436.
https://doi.org/10.3390/pharmaceutics16040436
APA Style
Magi, M. S., de Lafuente, Y., Quarta, E., Palena, M. C., Ardiles, P. d. R., Páez, P. L., Sonvico, F., Buttini, F., & Jimenez-Kairuz, A. F.
(2024). Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis. Pharmaceutics, 16(4), 436.
https://doi.org/10.3390/pharmaceutics16040436
